DXCM:NGS-DexCom Inc. (USD)

EQUITY | Medical Devices | Nasdaq Global Select

Last Closing

USD 131.91

Change

+2.20 (+1.70)%

Market Cap

USD 5.94B

Volume

2.02M

Analyst Target

USD 475.06
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-16 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
ALGN Align Technology Inc

+12.85 (+5.07%)

USD 19.07B
PODD Insulet Corporation

+8.51 (+4.43%)

USD 13.41B
SWAV Shockwave Medical Inc

N/A

USD 12.57B
BRKR Bruker Corporation

+1.68 (+2.60%)

USD 9.79B
MASI Masimo Corporation

+8.42 (+6.78%)

USD 6.66B
TMDX TransMedics Group Inc

+2.85 (+2.05%)

USD 4.52B
PRCT Procept Biorobotics Corp

-1.41 (-2.10%)

USD 3.54B
AXNX Axonics Modulation Technologie..

N/A

USD 3.42B
TNDM Tandem Diabetes Care Inc

-1.04 (-2.15%)

USD 3.20B
IRTC iRhythm Technologies Inc

-0.21 (-0.23%)

USD 3.02B

ETFs Containing DXCM

CIB0:XETRA VanEck Bionic Engineering.. 9.75 % 0.00 %

+0.17 (+1.57%)

USD 6.31M
EDOC:AU BetaShares Digital Health.. 9.28 % 0.00 %

-0.06 (1.57%)

N/A
CYBG:LSE VanEck Bionic Engineering.. 8.70 % 0.00 %

+0.15 (+1.57%)

USD 6.34M
EKG First Trust Nasdaq Lux Di.. 7.98 % 0.00 %

+0.13 (+1.57%)

USD 2.39M
CURE:XETRA VanEck Genomics and Healt.. 7.13 % 0.00 %

+0.13 (+1.57%)

USD 6.79M
SANE 6.79 % 0.00 %

N/A

N/A
SN5R:XETRA Global X Internet of Thin.. 6.69 % 0.00 %

+0.26 (+1.57%)

USD 3.06M
SNSR:SW Global X Internet of Thin.. 6.69 % 0.00 %

+0.29 (+1.57%)

USD 2.37M
CURG:LSE VanEck Genomics and Healt.. 6.37 % 0.00 %

+0.15 (+1.57%)

USD 6.79M
SNSG:LSE Global X Internet of Thin.. 5.96 % 0.00 %

+0.23 (+1.57%)

USD 2.37M
SNSR Global X Internet of Thin.. 5.93 % 0.69 %

+0.72 (+1.57%)

USD 0.28B
DDOC:XETRA Global X Telemedicine & D.. 5.84 % 0.00 %

+0.08 (+1.57%)

USD 5.39M
DDOC:F Global X Telemedicine & D.. 5.84 % 0.00 %

+0.01 (+1.57%)

USD 5.00M
EDOC:SW Global X Telemedicine & D.. 5.84 % 0.00 %

+0.05 (+1.57%)

USD 4.69M
FDHT:XETRA Fidelity Digital Health U.. 4.93 % 0.00 %

+0.06 (+1.57%)

USD 4.68M
DIP ETF Series Solutions 4.61 % 0.00 %

N/A

USD 1.15M
FDOC:LSE Fidelity Digital Health U.. 4.54 % 0.00 %

+0.06 (+1.57%)

USD 4.68M
FDHT 4.53 % 0.00 %

N/A

N/A
MEDI Harbor Health Care ETF 4.45 % 0.00 %

+0.16 (+1.57%)

USD 0.01B
UMDV:SW iShares US Medical Device.. 4.42 % 0.00 %

N/A

USD 0.24B
XSD2:LSE db x-trackers ShortDAX x2.. 4.39 % 0.00 %

-2.14 (1.57%)

USD 0.14B
DBPD:F Xtrackers - ShortDAX x2 D.. 4.39 % 0.00 %

N/A

USD 0.14B
DBPD:XETRA Xtrackers ShortDAX x2 Dai.. 4.39 % 0.00 %

-0.03 (1.57%)

USD 0.13B
IHI iShares U.S. Medical Devi.. 4.15 % 0.43 %

+0.21 (+1.57%)

USD 5.17B
MID American Century Mid Cap .. 3.98 % 0.00 %

+1.20 (+1.57%)

USD 0.07B
CARK Castleark Large Growth ET.. 3.77 % 0.00 %

+0.62 (+1.57%)

USD 0.34B
PFUT Putnam Sustainable Future.. 2.89 % 0.00 %

+0.22 (+1.57%)

USD 0.26B
MMLG First Trust Exchange-Trad.. 2.25 % 0.00 %

+0.39 (+1.57%)

USD 0.07B
VOT Vanguard Mid-Cap Growth I.. 1.46 % 0.07 %

+2.26 (+1.57%)

USD 13.18B
BFIT 0.00 % 0.50 %

N/A

N/A
IWP iShares Russell Mid-Cap G.. 0.00 % 0.24 %

+1.27 (+1.57%)

USD 13.91B
JKH 0.00 % 0.30 %

N/A

N/A
LNGR 0.00 % 0.50 %

N/A

N/A
GDNA 0.00 % 0.00 %

N/A

N/A
SLIM 0.00 % 0.50 %

N/A

N/A
VNSE Natixis ETF Trust II - Na.. 0.00 % 0.00 %

+0.35 (+1.57%)

USD 0.03B
EDOC Global X Telemedicine & D.. 0.00 % 0.00 %

+0.04 (+1.57%)

USD 0.05B
IMCG iShares Morningstar Mid-C.. 0.00 % 0.00 %

+0.73 (+1.57%)

N/A
CVGB:LSE VanEck Smart Home Active .. 0.00 % 0.00 %

+0.07 (+1.57%)

USD 0.01B
CAVE:LSE VanEck Smart Home Active .. 0.00 % 0.00 %

+0.21 (+1.57%)

USD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.30% 73% C 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.30% 73% C 65% D
Trailing 12 Months  
Capital Gain 10.82% 75% C 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.82% 75% C 61% D-
Trailing 5 Years  
Capital Gain 347.00% 95% A 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 347.00% 95% A 94% A
Average Annual (5 Year Horizon)  
Capital Gain 34.74% 81% B- 87% B+
Dividend Return 34.74% 81% B- 87% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 60.54% 49% F 27% F
Risk Adjusted Return 57.38% 94% A 85% B
Market Capitalization 5.94B 100% F 98% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Devices) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 81.80 20% 12%
Price/Book Ratio 25.38 8% 4%
Price / Cash Flow Ratio 66.93 4% 4%
Price/Free Cash Flow Ratio 57.12 6% 4%
Management Effectiveness  
Return on Equity 28.54% 97% 93%
Return on Invested Capital 9.97% 82% 79%
Return on Assets 6.79% 94% 90%
Debt to Equity Ratio 117.67% 28% 19%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.